Welcome and Foundation Update
Susan Thornton, CEO
Cutaneous Lymphoma Foundation

Patient Story
Jenni Burrows

Overview of Cutaneous Lymphomas Including Diagnosis & Staging
Steven Daveluy, MD
Wayne State University - Dermatology

Indolent/Skin Only Diagnosis (MF, LyP, CBCL, FMF)
Sima Rozati, MD
Johns Hopkins Dermatology

Aggressive/Systemic Diagnosis (SS, Transformed MF)
Jennifer DeSimone, MD, FAAD
Inova Schar Cancer Institute

Uncovering the FDA: Drug Development
Yvette Kasamon, MD
Center for Drug Evaluation and Research (CDER), FDA

Clinical Q&A Panel
Jennifer DeSimone, MD, FAAD
Inova Schar Cancer Institute

David Fisher, MD
Dana Farber Cancer Institute

Yvette Kasamon, MD
Center for Drug Evaluation and Research (CDER), FDA

Ellen Kim, MD
Perelman School of Medicine

Closing Comments
Susan Thornton, CEO
Cutaneous Lymphoma Foundation